Top Markets
Coin of the day
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp.

4171
Rank in Stocks #27717
GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes... GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.
Share Price
$0.54853323
Market Cap
$31.43M
Change (1 day)
0.58%
Change (1 year)
-18.14%
Country
TW
Trade GeneReach Biotechnology Corp. (4171)

Category

Price of 4171 with the market cap of B
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
4171
$0.54853323
Market Capitalization of GeneReach Biotechnology Corp.(4171)
Market Cap: $31.43M
As of August 2026 GeneReach Biotechnology Corp. has a market cap of $31.43M. This makes GeneReach Biotechnology Corp. the world's 27717th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of GeneReach Biotechnology Corp. from 2012 to 2026
4171 compared with Top 5 Most Popular stocks
Price of 4171 Asset B Mkt. of B Results
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$92,500.74 $31.43M
$5.301T +16,863,188.18%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$80,861.52 $31.43M
$4.634T +14,741,307.10%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$72,295.48 $31.43M
$4.143T +13,179,680.97%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$62,634.96 $31.43M
$3.589T +11,418,525.66%
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.
$49,854.07 $31.43M
$2.857T +9,088,514.97%